T cell immunity in hepatitis B and hepatitis C virus infection: Implications for autoimmunity

Autoimmunity Reviews

Volumn 4, Issue 2, 2005, Pages 82-95

  Ichiki, Yasunori ^a   He, Xiao Song ^a   Shimoda, Shinji ^b   Ishibashi, Hiromi ^c   Keeffe, Emmet B ^d   Rossaro, Lorenzo ^e   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KYUSHU UNIVERSITY   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; RIBAVIRIN;

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL FUNCTION; CELL PROLIFERATION; CELLULAR IMMUNITY; COMPARATIVE STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; DISEASE COURSE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER DISEASE; LIVER INJURY; MEDICAL LITERATURE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PREVALENCE; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VACCINATION; VIRUS HEPATITIS;

EID: 13844256575     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2004.12.003     Document Type: Review

References (85)

1. C.L. Lai, V. Ratziu, M.F. Yuen, and T. Poynard Viral hepatitis B Lancet 362 2003 2089
2. European Association for the Study of the Liver Consensus statement EASL International Consensus Conference on Hepatitis C. Paris, 26-28, February 1999 J. Hepatol. vol. 30 1999 956
3. M.E. Cramp, P. Carucci, J. Underhill, N.V. Naoumov, R. Williams, and P.T. Donaldson Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia J. Hepatol. 29 1998 207
4. M. Thursz, R. Yallop, R. Goldin, C. Trepo, and H.C. Thomas Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research Lancet 354 1999 2119
5. A. Mangia, R. Gentile, I. Cascavilla, M. Margaglione, M.R. Villani, and F. Stella HLA class II favors clearance of HCV infection and progression of the chronic liver damage J. Hepatol. 30 1999 984
6. G. Harcourt, S. Hellier, M. Bunce, J. Satsangi, J. Collier, and R. Chapman Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection J. Viral Hepatitis 8 2001 174
7. R. Thimme, D. Oldach, K.M. Chang, C. Steiger, S.C. Ray, and F.V. Chisari Determinants of viral clearance and persistence during acute hepatitis C virus infection J. Exp. Med. 194 2001 1395
8. F. Lechner, D.K. Wong, P.R. Dunbar, R. Chapman, R.T. Chung, and P. Dohrenwend Analysis of successful immune responses in persons infected with hepatitis C virus J. Exp. Med. 191 2000 1499
9. + T cells in chronic hepatitis C virus infection J. Immunol. 169 2002 3447
10. + cells in acute and chronic hepatitis C Hepatology 37 2003 1189
11. H.M. Diepolder, R. Zachoval, R.M. Hoffmann, E.A. Wierenga, T. Santantonio, and M.C. Jung Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection Lancet 346 1995 1006
12. G. Missale, R. Bertoni, V. Lamonaca, A. Valli, M. Massari, and C. Mori Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response J. Clin. Invest. 98 1996 706
13. J.T. Gerlach, H.M. Diepolder, M.C. Jung, N.H. Gruener, W.W. Schraut, and R. Zachoval Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C Gastroenterology 117 1999 933
14. V. Lamonaca, G. Missale, S. Urbani, M. Pilli, C. Boni, and C. Mori Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development Hepatology 30 1999 1088
15. + T-cell responsiveness in hepatitis C virus infection Hepatology 33 2001 267
16. S.L. Tsai, Y.F. Liaw, M.H. Chen, C.Y. Huang, and G.C. Kuo Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity Hepatology 25 1997 449
17. M.E. Cramp, P. Carucci, S. Rossol, S. Chokshi, G. Maertens, and R. Williams Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia Gut 44 1999 424
18. A. Grakoui, N.H. Shoukry, D.J. Woollard, J.H. Han, H.L. Hanson, and J. Ghrayeb HCV persistence and immune evasion in the absence of memory T cell help Science 302 2003 659
19. R. Thimme, J. Bukh, H.C. Spangenberg, S. Wieland, J. Pemberton, and C. Steiger Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease Proc. Natl. Acad. Sci. U. S. A. 99 2002 15661
20. G.J. Webster, S. Reignat, M.K. Maini, S.A. Whalley, G.S. Ogg, and A. King Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms Hepatology 32 2000 1117
21. L.G. Guidotti, R. Rochford, J. Chung, M. Shapiro, R. Purcell, and F.V. Chisari Viral clearance without destruction of infected cells during acute HBV infection Science 284 1999 825
22. M.R. Thursz, D. Kwiatkowski, C.E. Allsopp, B.M. Greenwood, H.C. Thomas, and A.V. Hill Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia N. Engl. J. Med. 332 1995 1065
23. T. Höhler, G. Gerken, A. Notghi, R. Lubjuhn, H. Taheri, and U. Protzer HLA-DRB1*1301 and*1302 protect against chronic hepatitis B J. Hepatol. 26 1997 503
24. + T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B Clin. Exp. Immunol. 113 1998 244
25. A. Franco, L.G. Guidotti, M.V. Hobbs, V. Pasquetto, and F.V. Chisari Pathogenetic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice J. Immunol. 159 1997 2001
26. S. Matsumura, K. Yamamoto, N. Shimada, N. Okano, R. Okamoto, and T. Suzuki High frequency of circulating HBcAg-specific CD8 T cells in hepatitis B infection: a flow cytometric analysis Clin. Exp. Immunol. 124 2001 435
27. G. Webster, and A. Bertoletti Quantity and quality of virus-specific CD8 cell response: relevance to the design of a therapeutic vaccine for chronic HBV infection Mol. Immunol. 38 2001 467
28. C. Ferrari, A. Penna, A. Bertoletti, A. Valli, A.D. Antoni, and T. Giuberti Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection J. Immunol. 145 1990 3442
29. + T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection J. Virol. 69 1995 3358
30. H.F. Löhr, W. Weber, J. Schlaak, B. Goergen, K.H. Meyer zum Büschenfelde, and G. Gerken Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants Hepatology 22 1995 61
31. A. Penna, M. Artini, A. Cavalli, M. Levrero, A. Bertoletti, and M. Pilli Long-lasting memory T cell responses following self-limited acute hepatitis B J. Clin. Invest. 98 1996 1185
32. H.F. Löhr, S. Krug, W. Herr, S. Weyer, J. Schlaak, and T. Wolfel Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis B Liver 18 1998 405
33. K. Sugimoto, J. Stadanlick, F. Ikeda, C. Brensinger, E.E. Furth, and H.J. Alter Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response Hepatology 37 2003 590
34. M.A. Rico, J.A. Quiroga, D. Subirá, S. Castañón, J.M. Esteban, and M. Pardo Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alfa Hepatology 33 2001 295
35. S.L. Tsai, P.J. Chen, M.Y. Lai, P.M. Yang, J.L. Sung, and J.H. Huang Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion J. Clin. Invest. 89 1992 87
36. B. Rehermann, P. Fowler, J. Sidney, J. Person, A. Redeker, and M. Brown The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis J. Exp. Med. 181 1995 1047
37. B. Rehermann, C. Ferrari, C. Pasquinelli, and F.V. Chisari The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response Nat. Med. 2 1996 1104
38. + T cells with viral clearance in acute hepatitis C J. Infect. Dis. 181 2000 1528
39. + T-cell expansion in patients with acute hepatitis C Hepatology 33 2001 287
40. + T cells in peripheral blood and liver using peptide-MHC tetramers Proc. Natl. Acad. Sci. U. S. A. 96 1999 5692
41. B. Rehermann, K.M. Chang, J.G. McHutchison, R. Kokka, M. Houghton, and F.V. Chisari Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection J. Clin. Invest. 98 1996 1432
42. A. Cerny, J.G. McHutchison, C. Pasquinelli, M.E. Brown, M.A. Brothers, and B. Grabscheid Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif J. Clin. Invest. 95 1995 521
43. M.J. Koziel, D. Dudley, N. Afdhal, A. Grakoui, C.M. Rice, and Q.L. Choo HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release J. Clin. Invest. 96 1995 2311
44. K. Hiroishi, H. Kita, M. Kojima, H. Okamoto, T. Moriyama, and T. Kaneko Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection Hepatology 25 1997 705
45. + T cells are required for protection from persistent hepatitis C virus infection J. Exp. Med. 197 2003 1645
46. + T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained Eur. J. Immunol. 30 2000 2479
47. Y. Nakamoto, S. Kaneko, H. Takizawa, Y. Kikumoto, M. Takano, and Y. Himeda Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers J. Med. Virol. 70 2003 51
48. + lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C J. Virol. 76 2002 12423
49. + T lymphocytes after infection with hepatitis C virus J. Virol. 75 2001 5550
50. S. Ward, G. Lauer, R. Isba, B. Walker, and P. Klenerman Cellular immune responses against hepatitis C virus: the evidence base 2002 Clin. Exp. Immunol. 128 2002 195
51. D.K. Wong, D.D. Dudley, N.H. Afdhal, J. Dienstag, C.M. Rice, and L. Wang Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection J. Immunol. 160 1998 1479
52. K.M. Chang, B. Rehermann, J.G. McHutchison, C. Pasquinelli, S. Southwood, and A. Sette Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus J. Clin. Invest. 100 1997 2376
53. A.L. Erickson, Y. Kimura, S. Igarashi, J. Eichelberger, M. Houghton, and J. Sidney The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes Immunity 15 2001 883
54. S. Cooper, A.L. Erickson, E.J. Adams, J. Kansopon, A.J. Weiner, and D.Y. Chien Analysis of a successful immune response against hepatitis C virus Immunity 10 1999 439
55. D.R. Nelson, C.G. Marousis, G.L. Davis, C.M. Rice, J. Wong, and M. Houghton The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C J. Immunol. 158 1997 1473
56. A.M. Grabowska, F. Lechner, P. Klenerman, P.J. Tighe, S. Ryder, and J.K. Ball Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection Eur. J. Immunol. 31 2001 2388
57. D.R. Nelson, C.G. Marousis, T. Ohno, G.L. Davis, and J.Y. Lau Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C Hepatology 28 1998 225
58. L.G. Guidotti, T. Ishikawa, M.V. Hobbs, B. Matzke, R. Schreiber, and F.V. Chisari Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes Immunity 4 1996 25
59. + T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection J. Virol. 77 2003 68
60. M.K. Maini, C. Boni, G.S. Ogg, A.S. King, S. Reignat, and C.K. Lee Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection Gastroenterology 117 1999 1386
61. Y. Sobao, H. Tomiyama, K. Sugi, M. Tokunaga, T. Ueno, and S. Saito The role of hepatitis B virus-specific memory CD8 T cells in the control of viral replication J. Hepatol. 36 2002 105
62. + cells in liver damage and viral control during persistent hepatitis B virus infection J. Exp. Med. 191 2000 1269
63. N. Shimada, K. Yamamoto, M.J. Kuroda, R. Terada, T. Hakoda, and H. Shimomura HBcAg-specific CD8 T cells play an important role in virus suppression, and acute flare-up is associated with the expansion of activated memory T cells J. Clin. Immunol. 23 2003 223
64. A. Bertoletti, C. Ferrari, F. Fiaccadori, A. Penna, R. Margolskee, and H.J. Schlicht HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen Proc. Natl. Acad. Sci. U. S. A. 88 1991 10445
65. R. Nayersina, P. Fowler, S. Guilhot, G. Missale, A. Cerny, and H.J. Schlicht HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection J. Immunol. 150 1993 4659
66. G. Fiore, I. Angarano, L. Caccetta, M. Serrone, E. Jirillo, and O. Schiraldi In-situ immunophenotyping study of hepatic-infiltrating cytotoxic cells in chronic active hepatitis C Eur. J. Gastroenterol. Hepatol. 9 1997 491
67. M.B. Gallè, R.M. DeFranco, D. Kerjaschki, R.G. Romanelli, P. Montalto, and P. Gentilini Ordered array of dendritic cells and CD8+ lymphocytes in portal infiltrates in chronic hepatitis C Histopathology 39 2001 373
68. V. Leroy, I. Vigan, J.F. Mosnier, T. Dufeu-Duchesne, M. Pernollet, and J.P. Zarski Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C Hepatology 38 2003 829
69. C.E. Harvey, J.J. Post, P. Palladinetti, A.J. Freeman, R.A. Ffrench, and R.K. Kumar Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation J. Leukoc. Biol. 74 2003 360
70. H. Kita, M. Kronenberg, and M.E. Gershwin Intrahepatic NKT cells M.E. Gershwin J.M. Vierling M.P. Manns Liver immunology 2002 Hanley and Belfus Philadelphia 85
71. H. Kita, O.V. Naidenko, M. Kronenberg, A.A. Ansari, P. Rogers, and X.S. He Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer Gastroenterology 123 2002 1031
72. K. Harada, K. Isse, K. Tsuneyama, H. Ohta, and Y. Nakanuma Accumulating CD57+CD3+ natural killer T cells are related to intrahepatic bile duct lesions in primary biliary cirrhosis Liver Int. 23 2003 94
73. + T cells reciprocally regulate acute graft versus host disease J. Exp. Med. 189 1999 1073
74. J. Boisvert, E.J. Kunkel, J.J. Campbell, E.B. Keeffe, E.C. Butcher, and H.B. Greenberg Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes J. Hepatol. 38 2003 67
75. M. Lucas, S. Gadola, U. Meier, N.T. Young, G. Harcourt, and A. Karadimitris Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection J. Virol. 77 2003 2251
76. + T cells and rapid elimination of effector cells by apoptosis Eur. J. Immunol. 28 1998 3448
77. K. Kakimi, L.G. Guidotti, Y. Koezuka, and F.V. Chisari Natural killer T cell activation inhibits hepatitis B virus replication in vivo J. Exp. Med. 192 2000 921
78. K. Kakimi, T.E. Lane, F.V. Chisari, and L.G. Guidotti Cutting edge: Inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver J. Immunol. 167 2001 6701
79. T. Kanto, N. Hayashi, T. Takehara, T. Tatsumi, N. Kuzushita, and A. Ito Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals J. Immunol. 162 1999 5584
80. S. Auffermann-Gretzinger, E.B. Keeffe, and S. Levy Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection Blood 97 2001 3171
81. C. Bain, A. Fatmi, F. Zoulim, J.P. Zarski, C. Trepo, and G. Inchauspe Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection Gastroenterology 120 2001 512
82. A. Dolganiuc, K. Kodys, A. Kopasz, C. Marshall, T. Do, and L. Romics Jr. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation J. Immunol. 170 2003 5615
83. R.S. Longman, A.H. Talal, I.M. Jacobson, M.L. Albert, and C.M. Rice Presence of functional dendritic cells in patients chronically infected with hepatitis C virus Blood 103 2004 1026
84. M. Larsson, E. Babcock, A. Grakoui, N. Shoukry, G. Lauer, and C. Rice Lack of phenotypic and functional impairment in dendritic cells from chimpanzees chronically infected with hepatitis C virus J. Virol. 78 2004 6151
85. H.F. Löhr, S. Pingel, W.O. Böcher, H. Bernhard, S. Herzog-Hauff, and S. Rose-John Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B-restoration by exogenous interleukin-12 Clin. Exp. Immunol. 130 2002 107